---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-059689"
form_type: "8-K"
ticker: "LCTX"
cik: "0000876343"
company_name: "Lineage Cell Therapeutics, Inc."
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T01:38:46.735545+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lineage Cell Therapeutics files $40M ATM equity offering via B. Riley

## Summary
- Prospectus supplement filed May 14, 2024 to sell up to $39,966,424 of common shares at-the-market.
- Sales agent is B. Riley Securities, Inc. under agreement dated March 22, 2024.
- Shares offered pursuant to effective shelf registration statement (File No. 333-277758).
- Legal opinion from Sheppard Mullin on share legality included as exhibit.

## SEC filing metadata
- accession: 0000950170-24-059689
- form_type: 8-K
- ticker: LCTX
- cik: 0000876343
- company_name: Lineage Cell Therapeutics, Inc.
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876343/000095017024059689/0000950170-24-059689-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876343/000095017024059689/lctx-20240514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-059689
- JSON: https://secwatch.observer/filing/0000950170-24-059689.json
- Plain text: https://secwatch.observer/filing/0000950170-24-059689.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.